Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AN INVESTIGATION INTENDED TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF GENOTROPIN IN CHILDREN WITH SGA DWARFISM WITHOUT EPIPHYSEAL CLOSURE. (RETROSPECTIVE STUDY)

NCT01897766 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01897766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AN INVESTIGATION INTENDED TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF GENOTROPIN IN CHILDREN WITH SGA DWARFISM WITHOUT EPIPHYSEAL CLOSURE. (RETROSPECTIVE STUDY)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
September 5, 2013
Completion date
June 7, 2017
Enrollment
482 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

small for gestational age (sga)